Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (4), 553-556
- https://doi.org/10.1016/0959-8049(95)00053-l
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Neuroblastoma cell detection by reverse transcriptase‐polymerase chain reaction (RT‐PCR) for tyrosine hydroxylase mRNAInternational Journal of Cancer, 1994
- Measurement of Dopamine, HVA and HMMA in Untimed Urine Samples: Establishment of Age-Related Reference Data in ChildrenAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reactionEuropean Journal of Cancer and Clinical Oncology, 1991
- Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in NeuroblastomaNew England Journal of Medicine, 1991
- Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.Journal of Clinical Pathology, 1989
- International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.Journal of Clinical Oncology, 1988